The expression levels of miR-155, miR-181b, miR-29a/b and miR-34a have been correlated to other prognostic biomarkers such IGHV, TP53 status or ZAP70 expression, affecting the clinical outcome of CLL patients [164,165,166,167]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.